SG149043A1 - N,n-dihalogenated amino acids and derivatives - Google Patents

N,n-dihalogenated amino acids and derivatives

Info

Publication number
SG149043A1
SG149043A1 SG200809398-1A SG2008093981A SG149043A1 SG 149043 A1 SG149043 A1 SG 149043A1 SG 2008093981 A SG2008093981 A SG 2008093981A SG 149043 A1 SG149043 A1 SG 149043A1
Authority
SG
Singapore
Prior art keywords
derivatives
amino acids
compositions
compounds
dihalogenated amino
Prior art date
Application number
SG200809398-1A
Other languages
English (en)
Inventor
Mansour Bassiri
Ramin Najafi
Lu Wang
Jane Yang
Original Assignee
Novacal Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novacal Pharmaceuticals Inc filed Critical Novacal Pharmaceuticals Inc
Publication of SG149043A1 publication Critical patent/SG149043A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/02—Compounds containing nitrogen-to-halogen bonds
    • C07C239/04—N-halogenated amines
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N41/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom
    • A01N41/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom containing a sulfur-to-oxygen double bond
    • A01N41/04—Sulfonic acids; Derivatives thereof
    • A01N41/08—Sulfonic acid halides; alpha-Hydroxy-sulfonic acids; Amino-sulfonic acids; Thiosulfonic acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Agronomy & Crop Science (AREA)
  • Wood Science & Technology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SG200809398-1A 2003-08-18 2004-08-17 N,n-dihalogenated amino acids and derivatives SG149043A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49620703P 2003-08-18 2003-08-18

Publications (1)

Publication Number Publication Date
SG149043A1 true SG149043A1 (en) 2009-01-29

Family

ID=34272488

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200809398-1A SG149043A1 (en) 2003-08-18 2004-08-17 N,n-dihalogenated amino acids and derivatives

Country Status (20)

Country Link
US (2) US7462361B2 (https=)
EP (2) EP1656095B1 (https=)
JP (1) JP4994033B2 (https=)
KR (1) KR101057609B1 (https=)
CN (1) CN1902158B (https=)
AR (1) AR047757A1 (https=)
AU (1) AU2004268546B2 (https=)
BR (1) BRPI0413660A (https=)
CA (1) CA2535926C (https=)
DK (1) DK1656095T3 (https=)
ES (1) ES2444845T3 (https=)
IL (1) IL173726A (https=)
MX (1) MXPA06001898A (https=)
NZ (1) NZ545654A (https=)
PL (1) PL1656095T3 (https=)
PT (1) PT1656095E (https=)
SG (1) SG149043A1 (https=)
SI (1) SI1656095T1 (https=)
TW (1) TWI376364B (https=)
WO (1) WO2005020896A2 (https=)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7393522B2 (en) * 2000-01-12 2008-07-01 Novabay Pharmaceuticals, Inc. Physiologically balanced, ionized, acidic solution and methodology for use in wound healing
JP5140218B2 (ja) 2001-09-14 2013-02-06 有限会社コヒーレントテクノロジー 表面洗浄・表面処理に適した帯電アノード水の製造用電解槽及びその製造法、並びに使用方法
EP1461474B1 (en) 2001-12-05 2011-11-30 Oculus Innovative Sciences, Inc. Method and apparatus for producing negative and positive oxidative reductive potential (orp) water
CN1902158B (zh) 2003-08-18 2011-04-06 诺华科尔制药公司 N,n-二卤代氨基酸及其衍生物
US9168318B2 (en) 2003-12-30 2015-10-27 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and methods of using the same
TWI386201B (zh) 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法
CA2602411C (en) 2005-03-23 2015-02-24 Oculus Innovative Sciences, Inc. Method of treating second and third degree burns using oxidative reductive potential water solution
CA2606734C (en) 2005-05-02 2016-06-21 Oculus Innovative Sciences, Inc. Method of using oxidative reductive potential water solution in dental applications
CA2624677A1 (en) * 2005-10-06 2007-04-19 Novacal Pharmaceuticals, Inc. System and method for the prevention of bacterial and fungal infections including urinary tract infections (uti) using n-halogenated amino acids
CA2637178C (en) 2006-01-20 2018-09-04 Oculus Innovative Sciences, Inc. Methods of preventing or treating sinusitis with oxidative reductive potential water solution
US20070292488A1 (en) * 2006-06-14 2007-12-20 Mansour Bassiri Method for treatment of wound treatment using aganocides
TW200843787A (en) * 2006-12-29 2008-11-16 Novabay Pharmaceuticals Inc N-halogenated amino compounds and derivatives; compositions and methods of using them
WO2008094663A2 (en) * 2007-01-31 2008-08-07 Adam Heller Electrochemical management of pain
UY31056A1 (es) * 2007-05-01 2008-10-31 Alcon Res Ltd Fromulaciones aminocido n-halogenado y metodos de limpieza y desinfeccion
UY31057A1 (es) * 2007-05-01 2008-10-31 Alcon Res Ltd Formulaciones de aminoacido n-halogenado que contiene acido alifatico
UY31059A1 (es) * 2007-05-01 2008-10-31 Alcon Res Ltd Formulaciones de aminoacido n-halogenado
UY31058A1 (es) * 2007-05-01 2008-10-31 Alcon Res Ltd Formulaciones de aminoacido n-halogenado con compuestos antiinflamatorios
US7524512B2 (en) * 2007-07-13 2009-04-28 Di Bartolomeo Joseph R Composition and method for the prevention and relief of the symptoms of an incompetent or patulous Eustachian tube
UY31055A1 (es) * 2008-02-01 2008-10-31 Alcon Res Ltd Sales antimicrobianas de aminoacido n-halogenado
ES2608047T3 (es) * 2008-04-10 2017-04-05 Waldemar Gottardi Composiciones que comprenden amina N-halogenada o N,N-dihalogenada para el tratamiento y profilaxis de infecciones broncopulmonares
CA2723262A1 (en) * 2008-04-15 2009-10-22 Waldemar Gottardi Compositions and devices for antisepsis and anticoagulation
NZ590878A (en) * 2008-08-12 2013-01-25 Novabay Pharmaceuticals Inc Antimicrobial gel formulations comprising an halogenated amine compound dispersed in a poly(acrylic acid) water-swellable polymer
JP5599808B2 (ja) 2008-11-07 2014-10-01 ノバベイ・ファーマシューティカルズ・インコーポレイテッド 抗菌性ｎ−塩素化組成物
WO2010054009A1 (en) * 2008-11-07 2010-05-14 Novabay Pharmaceuticals, Inc. Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions
WO2010091280A1 (en) 2009-02-06 2010-08-12 Alcon Research, Ltd. N-halogenated amino acid formulations comprising phosphine or amine oxides
PT2411410E (pt) * 2009-03-27 2015-10-09 Gojo Ind Inc Composições e métodos para screening e utilização de compostos que antagonizam interações esporo-superfície
WO2010124237A1 (en) * 2009-04-24 2010-10-28 Novabay Pharmaceuticals Inc. Methods of treating infections of the nail
WO2010148004A1 (en) 2009-06-15 2010-12-23 Oculus Innovative Sciences, Inc. Solution containing hypochlorous acid and methods of using same
CA2787461A1 (en) * 2010-02-04 2011-08-11 Novabay Pharmaceuticals, Inc. Polysaccharide based antimicrobial formulations
AU2011317223A1 (en) 2010-10-19 2013-05-23 Novabay Pharmaceuticals, Inc. Antimicrobial polyether and polyol compounds
BR112013027845A2 (pt) * 2011-05-18 2017-01-03 Ajinomoto Kk Imunoestimulante, ração, método para produzir um imunoestimulante, e, método para imunoestimulação
JP5952899B2 (ja) 2011-06-15 2016-07-13 アルエルエス グローバル アーベー う蝕象牙質組織の検出と除去
US9028807B2 (en) 2012-04-05 2015-05-12 Ues, Inc. Synthesis models for antimicrobial agents via the halogenation of organic/inorganic composites
SE536581C2 (sv) 2012-07-24 2014-03-11 Rls Global Ab Ett kit för behandling av sår eller liknande och ett preparat och metoder därav
DK3469117T3 (da) 2016-06-09 2022-02-28 De Nora Holdings Us Inc Elektrolytisk fremstilling af organiske chloraminopløsninger
US11172683B2 (en) * 2018-01-30 2021-11-16 Buckman Laboratories International, Inc. Synergistic combinations of monochloramine and organic acid, and methods of using the same for microbial control
CN111116406B (zh) * 2019-12-31 2020-12-25 吉林大学 一种能在物品表面形成杀菌涂层的卤胺及在物品表面形成杀菌涂层的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998945A (en) 1972-06-12 1976-12-21 National Patent Development Corporation Dental treatment
US3950536A (en) * 1974-02-01 1976-04-13 Sol Joseph Barer N,N-Dichloro substituted aminocarboxylic acids as bactericides and fungicides
US4015008A (en) * 1974-02-01 1977-03-29 National Patent Development Corporation N,N-dichloro substituted aminocarboxylic acids as microbiocides
US3966796A (en) * 1974-06-14 1976-06-29 Interx Research Corporation N-chloro-amino acid derivatives activity
US4045578A (en) * 1974-06-14 1977-08-30 Interx Research Corporation N-chloro-amino acid derivatives exhibiting antibacterial activity
US4386103A (en) * 1981-01-30 1983-05-31 Merck & Co., Inc. Dichloroamino acid derivatives useful as potent germicidal and fungicidal agents
US5055492A (en) 1985-06-14 1991-10-08 Masonic Medical Research Laboratory Method for affecting reproductive cycle of insects
US5096700A (en) * 1990-09-28 1992-03-17 The Procter & Gamble Company Halogenated aminohexanoates and aminobutyrates antimicrobial agents
DE4041703C2 (de) 1990-12-24 1993-10-21 Waldemar Dr Gottardi Alkalimetallsalze des N-Chlortaurins in kristalliner Form, Verfahren zu deren Herstellung und deren Verwendung
JP3759757B2 (ja) 1994-01-13 2006-03-29 相互薬工株式会社 殺菌剤
US5593714A (en) * 1994-12-06 1997-01-14 Hirsch; Gerald P. Method of pressure preservation of food products
US5753701A (en) * 1996-10-25 1998-05-19 University Of Kentucky N-chloro-N-methyl glucamine and N-chloro-N-methyl glucamine esters as novel safe agents for water disinfection
DE19712565A1 (de) 1997-03-25 1998-10-01 Thomas W Dr Stief Arzneimittel auf der Basis eines Singulett-Sauerstoff erzeugenden Agenzes
DE19816102C1 (de) 1998-04-10 1999-09-16 Waldemar Gottardi Verfahren zum Inaktivieren von Viren in Proteinlösungen, Verwendung von N-Chlortaurin in dem Verfahren sowie nach dem Verfahren hergestellte Proteinlösungen
CA2320556A1 (en) * 1999-09-29 2001-03-29 Queen's University At Kingston N,n-dichlorinated omega amino acids and uses thereof
AU2001285944A1 (en) 2000-09-14 2002-03-26 Waldemar Gottardi Fungicidal agent containing n-chlorotaurine and use thereof
FR2819723B1 (fr) 2001-01-23 2006-11-17 Arnaud Mainnemare Composition halogene, son procede de preparation et ses utilisations
CN1902158B (zh) 2003-08-18 2011-04-06 诺华科尔制药公司 N,n-二卤代氨基酸及其衍生物
AR046782A1 (es) 2003-12-17 2005-12-21 Rib X Pharmaceuticals Inc Compuestos heterociclicos de biarilo halogenados, composiciones farmaceuticas que los contienen, metodos para su elaboracion y su uso como medicamentos.
TWI386201B (zh) 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法
TW200843787A (en) 2006-12-29 2008-11-16 Novabay Pharmaceuticals Inc N-halogenated amino compounds and derivatives; compositions and methods of using them

Also Published As

Publication number Publication date
SI1656095T1 (sl) 2014-04-30
CA2535926C (en) 2012-10-09
AU2004268546A1 (en) 2005-03-10
WO2005020896A2 (en) 2005-03-10
EP1656095B1 (en) 2014-01-01
IL173726A (en) 2013-06-27
CN1902158A (zh) 2007-01-24
CN1902158B (zh) 2011-04-06
EP1656095A2 (en) 2006-05-17
PL1656095T3 (pl) 2014-04-30
TWI376364B (en) 2012-11-11
US7462361B2 (en) 2008-12-09
US20090023812A1 (en) 2009-01-22
EP1656095A4 (en) 2007-11-28
JP4994033B2 (ja) 2012-08-08
HK1103713A1 (en) 2007-12-28
NZ545654A (en) 2009-12-24
WO2005020896A3 (en) 2006-10-05
EP2725008A1 (en) 2014-04-30
AR047757A1 (es) 2006-02-22
CA2535926A1 (en) 2005-03-10
MXPA06001898A (es) 2006-05-31
BRPI0413660A (pt) 2006-10-24
DK1656095T3 (en) 2014-03-10
TW200520749A (en) 2005-07-01
JP2007502826A (ja) 2007-02-15
PT1656095E (pt) 2014-03-11
US20050065115A1 (en) 2005-03-24
AU2004268546B2 (en) 2011-12-08
KR101057609B1 (ko) 2011-08-18
ES2444845T3 (es) 2014-02-27
US7893109B2 (en) 2011-02-22
KR20060065701A (ko) 2006-06-14
IL173726A0 (en) 2006-07-05

Similar Documents

Publication Publication Date Title
SG149043A1 (en) N,n-dihalogenated amino acids and derivatives
TW200640445A (en) N-halogenated amino acids, N, N-dihalogenated amino acids and derivatives; compositions and methods of using them
MXPA05006685A (es) Antibioticos que contienen complejos de acido borinico y metodos de uso.
TW200612939A (en) Antibiotics containing borinic acid complexes and methods of use
SG135192A1 (en) Substituted pyrazoline compounds, their preparation and use as medicaments
IT1317735B1 (it) Sali di agenti antimicrobici.
GB0710121D0 (en) Antifungal agents
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
MX2007000392A (es) Derivados de 2-pirrolidona sustituida como fungicidas e insecticidas.
TW200745043A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
WO2007067559A3 (en) Antibacterial agents
ZA200809714B (en) Synergistic active ingredient combinations
MXPA02011039A (es) Combinaciones de productos activos fungicidas.
WO2012049327A3 (en) Pesticidal mixtures
TW200738699A (en) 4-Substituted pyrazoline compounds, their preparation and use as medicaments
ZA200508476B (en) Use of allicin as preservative, as disinfectant, as antimicrobial or as biocidal agent
PL367074A1 (en) Bioregulatory combination of active agents
TW200700420A (en) Novel triazolopyrimidine derivatives
MX2010001304A (es) Compuestos terapeuticos.
WO2007125383A3 (en) Topical drug delivery by iontophoresis
WO2010014943A3 (en) Methionine analogs and methods of using same
TW200745042A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
TW200420561A (en) Antimicrobial 1-aryl dihydropyridone compounds
PE20030125A1 (es) PIRIDO[1,2-c]PIRIMIDINA COMO AGENTES ANTIBACTERIANOS
TW200700421A (en) Novel triazolopyrimidine derivatives